fb tracking

Letter to the HHS Secretary Calling for the Resignations of Acting FDA Commissioner, Other Top Officials Responsible for Indefensible Approval of the Alzheimer’s Disease Drug Aducanumab

View as PDF

View press release

Public Citizen called on Secretary of Health and Human Services Xavier Becerra to request the resignations or seek the removal of the three officials most responsible for the agency’s indefensible decision to approve aducanumab for treatment of Alzheimer’s disease despite the lack of evidence that the drug provides any meaningful clinical benefit plus the fact that the drug has a well-documented risk of potentially serious brain injury: Acting FDA Commissioner Janet Woodcock, Center for Drug Evaluation and Research (CDER) Director Patrizia Cavazzoni, and CDER’s Office of Neuroscience Director Billy Dunn.

See Public Citizen’s other work on aducanumab.